{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:24:43Z","timestamp":1782545083228,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> To characterize the electro-clinical presentation of patients with pyridoxine-dependent epilepsy (PDE) and pyridoxal phosphate (PLP)-dependent epilepsy in order to determine whether some of them could be diagnosed as <jats:italic>de novo<\/jats:italic> West syndrome, i. e., West syndrome that starts after the age of 2 months without other types of seizures (focal seizures for instance) before the onset of epileptic spasms.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We analyzed data from an unpublished cohort of 28 genetically confirmed cases of PDE with antiquitine (ATQ) deficiency and performed a review of the literature looking for description of West syndrome in patients with either PDE with ATQ deficiency or PLP-dependent epilepsy with Pyridox(am)ine phosphate oxidase (PNPO) deficiency.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of the 28 cases from the ATQ deficiency French cohort, 5 had spasms. In four cases, spasms were associated with other types of seizures (myoclonus, focal seizures). In the last case, seizures started on the day of birth. None of these cases corresponded to <jats:italic>de novo<\/jats:italic> West syndrome. The review of the literature found only one case of PNPO deficiency presenting as <jats:italic>de novo<\/jats:italic> West syndrome and no case of ATQ deficiency.<\/jats:p><jats:p><jats:bold>Significance:<\/jats:bold> The presentation of PDE- and PLP-dependent epilepsy as <jats:italic>de novo<\/jats:italic> West syndrome is so exceptional that it probably does not justify a systematic trial of pyridoxine or PLP. We propose considering a therapeutic trial with these vitamins in West syndrome if spasms are associated with other seizure types or start before the age of 2 months.<\/jats:p>","DOI":"10.3389\/fped.2021.621200","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T04:43:27Z","timestamp":1614919407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature"],"prefix":"10.3389","volume":"9","author":[{"given":"Marc","family":"Gibaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Mention","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maurey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Barthez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Caubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mondher","family":"Chouchane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Doummar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mano\u00eblle","family":"Kossorotoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Dominique","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Roubertie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Van Bogaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1528-1157.1999.tb00773.x","article-title":"The descriptive epidemiology of infantile spasms among atlanta children","volume":"40","author":"Trevathan","year":"1999","journal-title":"Epilepsia."},{"key":"B2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/B978-0-444-52891-9.00063-4","article-title":"Infantile spasms","volume":"111","author":"Hrachovy","year":"2013","journal-title":"Handb Clin Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/epi4.12102","article-title":"Metabolic etiologies in West syndrome","volume":"3","author":"Salar","year":"2018","journal-title":"Epilepsia Open."},{"key":"B4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.pediatrneurol.2014.05.015","article-title":"Hereditary neurometabolic causes of infantile spasms in 80 children presenting to a tertiary care center","volume":"51","author":"Alrifai","year":"2014","journal-title":"Pediatr Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jimd.12060","article-title":"Disorders affecting vitamin B 6 metabolism","volume":"42","author":"Wilson","year":"2019","journal-title":"J Inherit Metab Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ymgme.2015.05.011","article-title":"Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: neurodevelopmental outcome","volume":"116","author":"Coughlin","year":"2015","journal-title":"Mol Genet Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.ajhg.2016.10.011","article-title":"Mutations in PROSC disrupt cellular pyridoxal phosphate homeostasis and cause vitamin-B 6 -dependent epilepsy","volume":"99","author":"Darin","year":"2016","journal-title":"Am J Hum Genet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1716","DOI":"10.1542\/peds.2012-1094","article-title":"Pyridoxine-dependent epilepsy with elevated urinary \u03b1-amino adipic semialdehyde in molybdenum cofactor deficiency","volume":"130","author":"Struys","year":"2012","journal-title":"Pediatrics."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1212\/WNL.0000000000000344","article-title":"Pyridoxine responsiveness in novel mutations of the PNPO gene","volume":"82","author":"Plecko","year":"2014","journal-title":"Neurology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awu051","article-title":"Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome","volume":"137","author":"Mills","year":"2014","journal-title":"Brain J. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/8904_2012_194","article-title":"Partial pyridoxine responsiveness in PNPO deficiency","volume":"9","author":"Pearl","year":"2013","journal-title":"JIMD Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1469-8749.2012.04347.x","article-title":"Long-term outcome in pyridoxine-dependent epilepsy: long-term outcome in pyridoxine-dependent epilepsy","volume":"54","author":"Bok","year":"2012","journal-title":"Dev Med Child Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2015.12.013","article-title":"Pyridoxine-dependent epilepsy: an expanding clinical spectrum","volume":"59","author":"van Karnebeek","year":"2016","journal-title":"Pediatr Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"F125","DOI":"10.1136\/fn.81.2.F125","article-title":"Pyridoxine dependent epilepsy: a suggestive electroclinical pattern","volume":"81","author":"Nabbout","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1093\/brain\/awq143","article-title":"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)","volume":"133","author":"Mills","year":"2010","journal-title":"Brain."},{"key":"B16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0387-7604(01)00306-0","article-title":"ACTH therapy of West syndrome: finnish views","volume":"23","author":"Riikonen","year":"2001","journal-title":"Brain Dev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.0013-9580.2004.30503.x","article-title":"Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone","volume":"45","author":"Kivity","year":"2004","journal-title":"Epilepsia."},{"key":"B19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2352-4642(18)30244-X","article-title":"Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial","volume":"2","author":"O'Callaghan","year":"2018","journal-title":"Lancet Child Adolesc Health."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1528-1167.2011.03127.x","article-title":"The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study: Lead Time and Age in Infantile Spasms","volume":"52","author":"O'Callaghan","year":"2011","journal-title":"Epilepsia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00431-008-0823-x","article-title":"Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry","volume":"168","author":"Basura","year":"2008","journal-title":"Eur J Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/jimd.12332","article-title":"Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to \u03b1-aminoadipic semialdehyde dehydrogenase deficiency","volume":"44","author":"Coughlin","year":"2021","journal-title":"J Inherit Metab Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1111\/epi.13557","article-title":"Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort","volume":"57","author":"Knupp","year":"2016","journal-title":"Epilepsia."},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.eplepsyres.2005.11.021","article-title":"Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy","volume":"70","author":"Ohtahara","year":"2006","journal-title":"Epilepsy Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1528-1167.2008.01816.x","article-title":"Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients","volume":"50","author":"Bennett","year":"2009","journal-title":"Epilepsia."},{"key":"B26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/WNL.55.2.309","article-title":"Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures","volume":"55","author":"Battaglioli","year":"2000","journal-title":"Neurology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10048-005-0221-8","article-title":"Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures","volume":"6","author":"Bennett","year":"2005","journal-title":"Neurogenetics."},{"key":"B28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1212\/WNL.0000000000001883","article-title":"Intragenic deletions of ALDH7A1 in pyridoxine-dependent epilepsy caused by Alu-Alu recombination","volume":"85","author":"Mefford","year":"2015","journal-title":"Neurology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/hmg\/ddi120","article-title":"Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5\u2032-phosphate oxidase","volume":"14","author":"Mills","year":"2005","journal-title":"Hum Mol Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12013-014-0404-8","article-title":"Screening of inherited metabolic disorders in infants with infantile Spasms","volume":"72","author":"Liu","year":"2015","journal-title":"Cell Biochem Biophys."},{"key":"B31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12519-018-0127-9","article-title":"Clinical characteristics of two cohorts of infantile spasms: response to pyridoxine or topiramate monotherapy","volume":"14","author":"Xue","year":"2018","journal-title":"World J Pediatr WJP."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1093\/hmg\/ddu199","article-title":"The genetic landscape of infantile spasms","volume":"23","author":"Michaud","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.pediatrneurol.2003.08.003","article-title":"A successful treatment with pyridoxal phosphate for West syndrome in hypophosphatasia","volume":"30","author":"Yamamoto","year":"2004","journal-title":"Pediatr Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0387-7604(87)80116-X","article-title":"Treatment of the West syndrome with high-dose pyridoxal phosphate","volume":"9","author":"Ohtsuka","year":"1987","journal-title":"Brain Dev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1528-1157.1993.tb00458.x","article-title":"Treatment of infantile spasms with high-dosage vitamin B6","volume":"34","author":"Pietz","year":"1993","journal-title":"Epilepsia."},{"key":"B36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.0013-9580.2004.19003.x","article-title":"Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication","volume":"45","author":"Debus","year":"2004","journal-title":"Epilepsia."},{"key":"B37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0387-7604(96)00024-1","article-title":"West syndrome: individualized ACTH therapy","volume":"18","author":"Heiskala","year":"1996","journal-title":"Brain Dev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/0028-3886.227281","article-title":"Addition of pyridoxine to prednisolone in the treatment of infantile spasms: a pilot, randomized controlled trial","volume":"66","author":"Kunnanayaka","year":"2018","journal-title":"Neurol India."},{"key":"B39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.seizure.2013.04.014","article-title":"Clinical spectrum and treatment outcome of West Syndrome in children from Northern India","volume":"22","author":"Kaushik","year":"2013","journal-title":"Seizure."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","article-title":"Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"78","author":"Go","year":"2012","journal-title":"Neurology."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.621200\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T04:43:29Z","timestamp":1614919409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.621200\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":40,"alternative-id":["10.3389\/fped.2021.621200"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.621200","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"article-number":"621200"}}